期刊文献+

胃原发性神经内分泌肿瘤18例临床病理分析 被引量:2

Clinical pathological analysis of 18 cases of primary gastric neuroen-docrine tumors
暂未订购
导出
摘要 目的分析并总结胃原发性神经内分泌肿瘤(NET)的临床病理特点。方法回顾性分析18例胃原发性NET的临床与病理资料。结果胃原发性NET的主要症状为上腹部不适、隐痛,部分伴有黑便。18例胃原发性NET中,NET14例,NEC3例,MANEC1例。突触素(Syn)和嗜铬粒素A(CgA)在低级别肿瘤中呈弥漫性强阳性表达,高级别肿瘤则阳性表达较弱。结论胃原发性NET病理诊断主要依靠镜下观察和免疫组织化学技术,正确的病理分型对治疗和预后评估有指导意义。 Objective To analyze and summarize the clinical pathological characteristics of primary gastric neuroen-docrine tumors (NET). Methods 18 cases of the clinical and pathological data of primary gastric NET was retrospectively analyzed. Results The main symptoms of primary gastric NET were discomfort and dull pain on upper abdomen, as well as melena in some of the patients.In 18 cases of primary gastric NET,14 cases were NET,3 cases were NEC and 1 case was MANEC.The expressions of synaptophysin(Syn) and chromaffin granule A(CgA) were strongly positive in tumors at a low level,while they were low in tumors at a high level. Conclusion The pathological diagnosis of primary gastric NET mainly depends on the microscopic observation and immunohistochemistry,correct pathologic classification is instructive to the treatment and prognosis assessment.
出处 《中国当代医药》 2013年第21期106-107,共2页 China Modern Medicine
关键词 胃原发性肿瘤 神经内分泌肿瘤 临床病理分析 Gastric primary tumor Neuroendocrine neoplasm Clinical pathological analysis
  • 相关文献

参考文献6

二级参考文献33

  • 1Yaov JC,Hassan M,Phan A,et al.One hundred years after "carcinoid ":epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States.J Clin Oncol,2008,26(18):3063-3072.
  • 2Yao JC,Shah MH,Ito T,et al.Everolimus for advanced pancreatic neuroendocrine tumors.N Engl J Med,2011,364(6):514-523.
  • 3Raymond E,Dahan L,Raoul JL,et al.Sunitinib malate for the treatment of pancreatic neuroendocrine tumors.N Engl J Med,2011,36(6):501-513.
  • 4Kl(o)ppel G,Couvelard A,Perren A,et al.ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors:towards a standardized approach to the diagnosis of gastroenteropancreatic neuroendocrine tumors and their prognostic stratification.Neuroendocrinology,2009,90 (2):162-166.
  • 5Klimstra DS,Modlin IR,Adsay NV,et al.Pathology reporting of neuroendocrine tumors:application of the Delphic consensus process to the development of a minimum pathology data set.Am J Surg Pathol,2010,34(3):300-313.
  • 6Bosman FT,Carneiro F,Hruban RH,et al.WHO classification of tumours of the digestive system.Lyon:IARC Press,2010.
  • 7Oberndorfer S.Karzinoide tumoren des dunndarms.Frankf ZPatrol,1907,1:426-432.
  • 8Williams ED,Siebenmann RE,Sobin LH.Histological typing of endocrine tumours.Geneva:World Health Organization,1980.
  • 9Hamilton SR,Aaltonen LA.World Health Organization classification of tumours.Pathology and genetics of tumours of the digestive system.Lyon:IARC Press,2000.
  • 10Rindi G,Kl(o)ppel G,Alhman H,et al.TNM staging of foregut (neuro) endocrine tumors:a consensus proposal including a grading system.Virchows Arch,2006,449(4):395-401.

共引文献320

同被引文献13

  • 1Metzgeroth G,Striibel P,Baumbusch T,et al.Hepatoid adenocarcinoma-review of the literature illustrated by a rare case originating in the peritoneal cavity[J].Onkologie,2010,33(5):263-269.
  • 2Kono K,Amemiya H,Sekikawa T,et al.Clinicopathologic features of gastric cancers producing alpha-fetoprotein[J].Dig Surg,2002,19(5):359-365.
  • 3Baek SK,Han SW,Oh DY,et al.Clinicopathologic characteristics and treatment outcomes of hepatoid adenocarcinoma of the stomach,a rare but unique subtype of gastric cancer[J].BMC Gastroenterol,2011,11(1):56.
  • 4Kumashiro Y,Yao T,Aishima S,et al.Hepatoid adenocarcinoma of the stomach:histogenesis and progression in association with intestinal phenotype[J].Hum Pathol,2007,38(6):857-863.
  • 5Yildiz O,Ozguroglu M,Yarrmaz T,et al.Gastroenteropancreatic neuroendocrine tumors:10-year experience in a single center[J].Med Oncol,2010,27(4):1050-1056.
  • 6Rindi G,Kloppel G,Albman H,et al.TNM staging of foregut (neuro)endocrine tumors:a consensus proposal including a grading system[J].Virchows Arch,2006,449(4):395-401.
  • 7Susini C,Buscail L.Rationale for the use of somatostatin analogs as antitumor agents[J].Ann Oncol,2006,17(12):1733-1742.
  • 8Mejias M,Garcia-Pras E,Tiani C,et al.The somatostatin analogue octreotide inhibits angiogenesis in the earliest,but not in advanced,stages of portal hypertension in rats[J].J Cell Mol Med,2008,12(5A):1690-1699.
  • 9Sara Massironi,Valentina Sciola,Maddalena Peracchi,Clorinda Ciafardini,Matilde Pia Spampatti,Dario Conte.Neuroendocrine tumors of the gastro-entero-pancreatic system[J].World Journal of Gastroenterology,2008,14(35):5377-5384. 被引量:45
  • 10中国胃肠胰神经内分泌肿瘤病理学诊断共识[J].中华病理学杂志,2011,40(4):257-262. 被引量:294

引证文献2

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部